MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on May 21, 2004; DOI: 10.1124/mol.104.000398


This Article
Right arrow Full Text (PDF)
Right arrow Correction
Right arrow All Versions of this Article:
mol.104.000398v1
66/2/312    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ayoub, M. A.
Right arrow Articles by Jockers, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ayoub, M. A.
Right arrow Articles by Jockers, R.


Received for publication March 12, 2004.
Revised May 12, 2004.
Accepted for publication May 13, 2004.

Preferential formation of MT1/MT2 melatonin receptor heterodimers with distinct ligand interaction properties compared to MT2 homodimers

Mohammed A. Ayoub 1, Angelique Levoye 1, Philippe Delagrange 2, Ralf Jockers 1*

1 Institut Cochin 2 Institut Servier

* Address correspondence to: E-mail: jockers{at}cochin.inserm.fr

Abstract

Heterodimerization has been documented for several members of the G protein-coupled receptor (GPCR) super-family, including the closely related MT1 and MT2 melatonin receptors. However, the relative abundance of hetero- versus homodimers and the specific properties, which can be attributed to each form, are difficult to determine. Using a bioluminescence resonance energy transfer (BRET) donor saturation assay, we show that half maximal MT1/MT2 heterodimer formation is reached for expression levels as low as {approx}4000 receptors/cell. The relative propensity of MT1 homodimer and MT1/MT2 heterodimer formation are similar, whereas that for the MT2 homodimer formation is 3-4 fold lower. These data indicate that both the relative expression level of each receptor isoform and the affinities between monomers may determine the actual proportion of homo- and heterodimers. The specific interaction of ligands with the MT1/MT2 heterodimer was studied using a BRET-based assay as a read out for the conformational changes of the heterodimer. A MT1/MT2 heterodimer-specific profile as well as ligands selective for the MT1/MT2 heterodimer compared to the MT2 homodimer could be identified. Classical radioligand binding and BRET studies suggest that heterodimers contain two functional ligand binding sites that maintain their respective selectivity for MT1 and MT2 ligands. Occupation of either binding site is sufficient to induce a conformational change within the heterodimer. Taken together, we show that the probability of GPCR heterodimer formation may be equal or even higher than that of the corresponding homodimers and that specific properties of heterodimers can be revealed using a BRET-based ligand/receptor interaction assay.


Key words: Melatonin, Fluorescence techniques, Receptor binding studies


This article has been cited by other articles:


Home page
Mol. Pharmacol.Home page
F. Gao, K. G. Harikumar, M. Dong, P. C.-H. Lam, P. M. Sexton, A. Christopoulos, A. Bordner, R. Abagyan, and L. J. Miller
Functional Importance of a Structurally Distinct Homodimeric Complex of the Family B G Protein-Coupled Secretin Receptor
Mol. Pharmacol., August 1, 2009; 76(2): 264 - 274.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
A. Levoye, K. Balabanian, F. Baleux, F. Bachelerie, and B. Lagane
CXCR7 heterodimerizes with CXCR4 and regulates CXCL12-mediated G protein signaling
Blood, June 11, 2009; 113(24): 6085 - 6093.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
I. Kalatskaya, Y. A. Berchiche, S. Gravel, B. J. Limberg, J. S. Rosenbaum, and N. Heveker
AMD3100 Is a CXCR7 Ligand with Allosteric Agonist Properties
Mol. Pharmacol., May 1, 2009; 75(5): 1240 - 1247.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P. Hermand, F. Pincet, S. Carvalho, H. Ansanay, E. Trinquet, M. Daoudi, C. Combadiere, and P. Deterre
Functional Adhesiveness of the CX3CL1 Chemokine Requires Its Aggregation: ROLE OF THE TRANSMEMBRANE DOMAIN
J. Biol. Chem., October 31, 2008; 283(44): 30225 - 30234.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
E. E. Benarroch
Suprachiasmatic nucleus and melatonin: Reciprocal interactions and clinical correlations
Neurology, August 19, 2008; 71(8): 594 - 598.
[Full Text] [PDF]


Home page
BloodHome page
B. Lagane, K. Y. C. Chow, K. Balabanian, A. Levoye, J. Harriague, T. Planchenault, F. Baleux, N. Gunera-Saad, F. Arenzana-Seisdedos, and F. Bachelerie
CXCR4 dimerization and {beta}-arrestin-mediated signaling account for the enhanced chemotaxis to CXCL12 in WHIM syndrome
Blood, July 1, 2008; 112(1): 34 - 44.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. C. Y. Choi, J. Simon, K. W. K. Tsim, and E. A. Barnard
Constitutive and Agonist-induced Dimerizations of the P2Y1 Receptor: RELATIONSHIP TO INTERNALIZATION AND SCAFFOLDING
J. Biol. Chem., April 18, 2008; 283(16): 11050 - 11063.
[Abstract] [Full Text] [PDF]


Home page
J EndocrinolHome page
L. Szidonya, M. Cserzo, and L. Hunyady
Dimerization and oligomerization of G-protein-coupled receptors: debated structures with established and emerging functions
J. Endocrinol., March 1, 2008; 196(3): 435 - 453.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
C. Couturier, C. Sarkis, K. Seron, S. Belouzard, P. Chen, A. Lenain, L. Corset, J. Dam, V. Vauthier, A. Dubart, et al.
Silencing of OB-RGRP in mouse hypothalamic arcuate nucleus increases leptin receptor signaling and prevents diet-induced obesity
PNAS, December 4, 2007; 104(49): 19476 - 19481.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. ProteomicsHome page
A. M. Daulat, P. Maurice, C. Froment, J.-L. Guillaume, C. Broussard, B. Monsarrat, P. Delagrange, and R. Jockers
Purification and Identification of G Protein-coupled Receptor Protein Complexes under Native Conditions
Mol. Cell. Proteomics, May 1, 2007; 6(5): 835 - 844.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
M. A. Ayoub, D. Maurel, V. Binet, M. Fink, L. Prezeau, H. Ansanay, and J.-P. Pin
Real-Time Analysis of Agonist-Induced Activation of Protease-Activated Receptor 1/G{alpha}i1 Protein Complex Measured by Bioluminescence Resonance Energy Transfer in Living Cells
Mol. Pharmacol., May 1, 2007; 71(5): 1329 - 1340.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
J.-P. Pin, R. Neubig, M. Bouvier, L. Devi, M. Filizola, J. A. Javitch, M. J. Lohse, G. Milligan, K. Palczewski, M. Parmentier, et al.
International Union of Basic and Clinical Pharmacology. LXVII. Recommendations for the Recognition and Nomenclature of G Protein-Coupled Receptor Heteromultimers
Pharmacol. Rev., March 1, 2007; 59(1): 5 - 13.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. C. Goin and N. M. Nathanson
Quantitative Analysis of Muscarinic Acetylcholine Receptor Homo- and Heterodimerization in Live Cells: REGULATION OF RECEPTOR DOWN-REGULATION BY HETERODIMERIZATION
J. Biol. Chem., March 3, 2006; 281(9): 5416 - 5425.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
J. A. S. Rada and A. F. Wiechmann
Melatonin Receptors in Chick Ocular Tissues: Implications for a Role of Melatonin in Ocular Growth Regulation
Invest. Ophthalmol. Vis. Sci., January 1, 2006; 47(1): 25 - 33.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
W. Guo, L. Shi, M. Filizola, H. Weinstein, and J. A. Javitch
From The Cover: Crosstalk in G protein-coupled receptors: Changes at the transmembrane homodimer interface determine activation
PNAS, November 29, 2005; 102(48): 17495 - 17500.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
S. C. Prinster, C. Hague, and R. A. Hall
Heterodimerization of G Protein-Coupled Receptors: Specificity and Functional Significance
Pharmacol. Rev., September 1, 2005; 57(3): 289 - 298.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2004 by the American Society for Pharmacology and Experimental Therapeutics